Barclays’s iPath Short Enhanced MSCI Emerging Markets Index ETN EMSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,720
Closed -$436K 7307
2017
Q1
$436K Buy
+14,720
New +$1.62M ﹤0.01% 3536
2015
Q1
Sell
-1,200
Closed -$48K 7606
2014
Q4
$48K Hold
1,200
﹤0.01% 5767
2014
Q3
$44K Hold
1,200
﹤0.01% 5990
2014
Q2
$50K Hold
1,200
﹤0.01% 5950
2014
Q1
$56K Hold
1,200
﹤0.01% 5908
2013
Q4
$52K Hold
1,200
﹤0.01% 6165
2013
Q3
$55K Hold
1,200
﹤0.01% 5999
2013
Q2
$64K Buy
+1,200
New +$64K ﹤0.01% 6140

Barclays's EMSA Position: Q2 2017 in Review

Barclays sold out of iPath Short Enhanced MSCI Emerging Markets Index ETN (EMSA) in Q2 2017, closing a stake of 14,720 shares — an estimated $436K sold.

Barclays first reported a position in EMSA in Q2 2013 and held it in 8 quarters. The position peaked at $436K in Q1 2017. 0 funds tracked by Wall St. Rank hold EMSA as of Q2 2017.

  • Barclays reported no remaining iPath Short Enhanced MSCI Emerging Markets Index ETN position as of Q2 2017 after selling out during the quarter.
  • Barclays sold 14,720 iPath Short Enhanced MSCI Emerging Markets Index ETN shares in Q2 2017, an estimated $436K.
  • Barclays first reported a position in iPath Short Enhanced MSCI Emerging Markets Index ETN in Q2 2013 and held it in 8 quarters.
  • Barclays's iPath Short Enhanced MSCI Emerging Markets Index ETN position peaked at $436K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held iPath Short Enhanced MSCI Emerging Markets Index ETN as of Q2 2017.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.